Press Releases

Press Releases

May 15, 2018
Surface Oncology to Present at 2018 UBS Global Healthcare Conference
April 23, 2018
Surface Oncology Announces Closing of $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement
April 18, 2018
Surface Oncology Announces $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement
March 20, 2018
Surface Oncology Announces First Patient Dosed in Phase 1 Clinical Trial of SRF231
February 22, 2018
Surface Oncology Expands Board Of Directors
February 12, 2018
Surface Oncology Promotes Jeff Goater to Chief Executive Officer